BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Y, Wan Q, Xu M, Zhou Q, Chen X, Yin D, He H, He M. Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function. Chem Biol Interact 2019;309:108723. [PMID: 31228469 DOI: 10.1016/j.cbi.2019.06.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Jing H, Xie R, Bai Y, Duan Y, Sun C, Wang Y, Cao R, Ling Z, Qu X. The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology. Front Pharmacol 2021;12:755653. [PMID: 34803698 DOI: 10.3389/fphar.2021.755653] [Reference Citation Analysis]
2 Jiang B, Yang YJ, Dang WZ, Li H, Feng GZ, Yu XC, Shen XY, Hu XG. Astragaloside IV reverses simvastatin-induced skeletal muscle injury by activating the AMPK-PGC-1α signalling pathway. Phytother Res 2020;34:1175-84. [PMID: 31823428 DOI: 10.1002/ptr.6593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 He H, Wang L, Qiao Y, Zhou Q, Yang B, Yin L, Yin D, He M. Vinegar/Tetramethylpyrazine Induces Nutritional Preconditioning Protecting the Myocardium Mediated by VDAC1. Oxid Med Cell Longev 2021;2021:6670088. [PMID: 33995824 DOI: 10.1155/2021/6670088] [Reference Citation Analysis]
4 Tan YQ, Chen HW, Li J. Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases. Drug Des Devel Ther 2020;14:3731-46. [PMID: 32982178 DOI: 10.2147/DDDT.S272355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chang X, Zhang W, Zhao Z, Ma C, Zhang T, Meng Q, Yan P, Zhang L, Zhao Y. Regulation of Mitochondrial Quality Control by Natural Drugs in the Treatment of Cardiovascular Diseases: Potential and Advantages. Front Cell Dev Biol 2020;8:616139. [PMID: 33425924 DOI: 10.3389/fcell.2020.616139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Wang R, Wang M, Zhou J, Wu D, Ye J, Sun G, Sun X. Saponins in Chinese Herbal Medicine Exerts Protection in Myocardial Ischemia-Reperfusion Injury: Possible Mechanism and Target Analysis. Front Pharmacol 2020;11:570867. [PMID: 33597866 DOI: 10.3389/fphar.2020.570867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang L, Lu Z, Zhao X. Targeting Bcl-2 for cancer therapy. Biochim Biophys Acta Rev Cancer 2021;1876:188569. [PMID: 34015412 DOI: 10.1016/j.bbcan.2021.188569] [Reference Citation Analysis]
8 Zang Y, Wan J, Zhang Z, Huang S, Liu X, Zhang W. An updated role of astragaloside IV in heart failure. Biomedicine & Pharmacotherapy 2020;126:110012. [DOI: 10.1016/j.biopha.2020.110012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
9 He H, Qiao Y, Zhou Q, Wang Z, Chen X, Liu D, Yin D, He M. Iron Overload Damages the Endothelial Mitochondria via the ROS/ADMA/DDAHII/eNOS/NO Pathway. Oxid Med Cell Longev. 2019;2019:2340392. [PMID: 31781327 DOI: 10.1155/2019/2340392] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Chen J, Han X, Deng J, Zhang J, Li L, Ni J, Huang Y, Xie X, Chen S, Ke L, Gao X, Wang W, Fan G. An injectable hydrogel based on phenylboronic acid hyperbranched macromer encapsulating gold nanorods and Astragaloside IV nanodrug for myocardial infarction. Chemical Engineering Journal 2021;413:127423. [DOI: 10.1016/j.cej.2020.127423] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
11 Qiao Y, Wang L, Hu T, Yin D, He H, He M. Capsaicin protects cardiomyocytes against lipopolysaccharide-induced damage via 14-3-3γ-mediated autophagy augmentation. Front Pharmacol 2021;12:659015. [PMID: 33986684 DOI: 10.3389/fphar.2021.659015] [Reference Citation Analysis]
12 Yang B, Li H, Qiao Y, Zhou Q, Chen S, Yin D, He H, He M. Tetramethylpyrazine Attenuates the Endotheliotoxicity and the Mitochondrial Dysfunction by Doxorubicin via 14-3-3γ/Bcl-2. Oxid Med Cell Longev 2019;2019:5820415. [PMID: 31885804 DOI: 10.1155/2019/5820415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wu W, Yang B, Qiao Y, Zhou Q, He H, He M. Kaempferol protects mitochondria and alleviates damages against endotheliotoxicity induced by doxorubicin. Biomed Pharmacother 2020;126:110040. [PMID: 32145585 DOI: 10.1016/j.biopha.2020.110040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Qiao Y, Hu T, Yang B, Li H, Chen T, Yin D, He H, He M. Capsaicin Alleviates the Deteriorative Mitochondrial Function by Upregulating 14-3-3η in Anoxic or Anoxic/Reoxygenated Cardiomyocytes. Oxid Med Cell Longev 2020;2020:1750289. [PMID: 32190168 DOI: 10.1155/2020/1750289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li B, Yu J, Liu P, Zeng T, Zeng X. Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway. Ann Transl Med 2021;9:1435. [PMID: 34733987 DOI: 10.21037/atm-21-4080] [Reference Citation Analysis]
16 Mu JK, Li YQ, Shi TT, Yu LP, Yang YQ, Gu W, Li JP, Yu J, Yang XX. Remedying the Mitochondria to Cure Human Diseases by Natural Products. Oxid Med Cell Longev 2020;2020:5232614. [PMID: 32733635 DOI: 10.1155/2020/5232614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]